192 related articles for article (PubMed ID: 35891482)
41. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
[TBL] [Abstract][Full Text] [Related]
42. Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice.
Samsa MM; Dupuy LC; Beard CW; Six CM; Schmaljohn CS; Mason PW; Geall AJ; Ulmer JB; Yu D
Mol Ther; 2019 Apr; 27(4):850-865. PubMed ID: 30770173
[TBL] [Abstract][Full Text] [Related]
43. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus.
Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884
[TBL] [Abstract][Full Text] [Related]
44. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates.
Ko SY; Akahata W; Yang ES; Kong WP; Burke CW; Honnold SP; Nichols DK; Huang YS; Schieber GL; Carlton K; DaSilva L; Traina-Dorge V; Vanlandingham DL; Tsybovsky Y; Stephens T; Baxa U; Higgs S; Roy CJ; Glass PJ; Mascola JR; Nabel GJ; Rao SS
Sci Transl Med; 2019 May; 11(492):. PubMed ID: 31092692
[TBL] [Abstract][Full Text] [Related]
45. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
Barber TL; Walton TE; Lewis KJ
Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
[TBL] [Abstract][Full Text] [Related]
47. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
Rosas CT; Paessler S; Ni H; Osterrieder N
Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
[TBL] [Abstract][Full Text] [Related]
48. Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
Erasmus JH; Seymour RL; Kaelber JT; Kim DY; Leal G; Sherman MB; Frolov I; Chiu W; Weaver SC; Nasar F
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187545
[TBL] [Abstract][Full Text] [Related]
49. Current Understanding of the Molecular Basis of Venezuelan Equine Encephalitis Virus Pathogenesis and Vaccine Development.
Sharma A; Knollmann-Ritschel B
Viruses; 2019 Feb; 11(2):. PubMed ID: 30781656
[TBL] [Abstract][Full Text] [Related]
50. Aerosol infection of cynomolgus macaques with enzootic strains of venezuelan equine encephalitis viruses.
Reed DS; Lind CM; Sullivan LJ; Pratt WD; Parker MD
J Infect Dis; 2004 Mar; 189(6):1013-7. PubMed ID: 14999604
[TBL] [Abstract][Full Text] [Related]
51. Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.
Atasheva S; Kim DY; Frolova EI; Frolov I
J Virol; 2015 Jan; 89(1):71-82. PubMed ID: 25320296
[TBL] [Abstract][Full Text] [Related]
52. REVIEW PAPER: pathology of animal models of alphavirus encephalitis.
Steele KE; Twenhafel NA
Vet Pathol; 2010 Sep; 47(5):790-805. PubMed ID: 20551475
[TBL] [Abstract][Full Text] [Related]
53. Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.
Cecil C; West A; Collier M; Jurgens C; Madden V; Whitmore A; Johnston R; Moore DT; Swanstrom R; Davis NL
Virology; 2007 Jun; 362(2):362-73. PubMed ID: 17275057
[TBL] [Abstract][Full Text] [Related]
54. Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.
Johnston RE; Johnson PR; Connell MJ; Montefiori DC; West A; Collier ML; Cecil C; Swanstrom R; Frelinger JA; Davis NL
Vaccine; 2005 Oct; 23(42):4969-79. PubMed ID: 16005121
[TBL] [Abstract][Full Text] [Related]
55. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
[TBL] [Abstract][Full Text] [Related]
56. Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice.
Lee JS; Groebner JL; Hadjipanayis AG; Negley DL; Schmaljohn AL; Welkos SL; Smith LA; Smith JF
Vaccine; 2006 Nov; 24(47-48):6886-92. PubMed ID: 16828936
[TBL] [Abstract][Full Text] [Related]
57. Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effects.
Osada T; Berglund P; Morse MA; Hubby B; Lewis W; Niedzwiecki D; Yang XY; Hobeika A; Burnett B; Devi GR; Clay TM; Smith J; Kim Lyerly H
Cancer Immunol Immunother; 2012 Nov; 61(11):1941-51. PubMed ID: 22488274
[TBL] [Abstract][Full Text] [Related]
58. Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge.
Kafai NM; Williamson LE; Binshtein E; Sukupolvi-Petty S; Gardner CL; Liu J; Mackin S; Kim AS; Kose N; Carnahan RH; Jung A; Droit L; Reed DS; Handley SA; Klimstra WB; Crowe JE; Diamond MS
J Exp Med; 2022 Apr; 219(4):. PubMed ID: 35297953
[TBL] [Abstract][Full Text] [Related]
59. Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.
Ljungberg K; Whitmore AC; Fluet ME; Moran TP; Shabman RS; Collier ML; Kraus AA; Thompson JM; Montefiori DC; Beard C; Johnston RE
J Virol; 2007 Dec; 81(24):13412-23. PubMed ID: 17913817
[TBL] [Abstract][Full Text] [Related]
60. Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule.
Rusnak JM; Glass PJ; Weaver SC; Sabourin CL; Glenn AM; Klimstra W; Badorrek CS; Nasar F; Ward LA
Viruses; 2019 Aug; 11(9):. PubMed ID: 31480472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
